SWS Hemodialysis Care Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	806.82	567.1	689.96	381.89	283.1
Other Revenue	-	0.18	0.15	0.12	0.17
Revenue	806.82	567.27	690.11	382.01	283.28
Revenue Growth (YoY)	42.23%	-17.80%	80.65%	34.86%	11.35%
Cost of Revenue	-	320.46	354.38	217.09	168.83
Gross Profit	806.82	246.81	335.73	164.93	114.44
Selling, General & Admin	-	157.6	132.21	97.7	80.34
Research & Development	-	54.24	37.67	23.13	17.74
Other Operating Expenses	623.23	4.55	-17.35	-8.68	-4.77
Operating Expenses	623.23	214.65	155.93	115.29	95.22
Operating Income	183.6	32.16	179.8	49.64	19.23
Interest Expense	-	-0.28	-0.16	-0.8	-1.61
Interest & Investment Income	-	25.56	25.72	2.61	4.8
Currency Exchange Gain (Loss)	-	0.93	0.68	0.74	-0.2
Other Non Operating Income (Expenses)	-20.1	-0.58	2.67	-1.05	-0.74
EBT Excluding Unusual Items	163.49	57.79	208.71	51.14	21.48
Gain (Loss) on Sale of Investments	-	9.14	10.79	0.78	-
Gain (Loss) on Sale of Assets	-	-0.28	0.45	-0.34	0.04
Asset Writedown	-	-8.01	-	-	-0.05
Other Unusual Items	-	9.78	-	11.77	0.59
Pretax Income	163.49	68.42	219.95	63.36	22.05
Income Tax Expense	20.38	4.42	27.74	6.46	3.91
Earnings From Continuing Operations	143.12	64	192.21	56.9	18.14
Minority Interest in Earnings	-	6.89	2.29	2.33	1.33
Net Income	143.12	70.89	194.5	59.24	19.47
Net Income to Common	143.12	70.89	194.5	59.24	19.47
Net Income Growth	101.89%	-63.55%	228.34%	204.20%	-5.55%
Shares Outstanding (Basic)	321	320	321	321	241
Shares Outstanding (Diluted)	321	320	321	321	241
Shares Change (YoY)	0.45%	-0.49%	0.03%	33.29%	10.47%
EPS (Basic)	0.45	0.22	0.61	0.18	0.08
EPS (Diluted)	0.45	0.22	0.61	0.18	0.08
EPS Growth	100.99%	-63.37%	228.25%	128.22%	-14.50%
Free Cash Flow	-	59.97	-47.97	232.9	4.69
Free Cash Flow Per Share	-	0.19	-0.15	0.72	0.02
Dividend Per Share	-	0.100	0.269	-	-
Dividend Growth	-	-62.76%	-	-	-
Gross Margin	100.00%	43.51%	48.65%	43.17%	40.40%
Operating Margin	22.75%	5.67%	26.05%	13.00%	6.79%
Profit Margin	17.74%	12.50%	28.18%	15.51%	6.87%
Free Cash Flow Margin	-	10.57%	-6.95%	60.97%	1.65%
EBITDA	202.32	50.88	196.03	63.94	32.99
EBITDA Margin	25.08%	8.97%	28.41%	16.74%	11.65%
D&A For EBITDA	18.73	18.73	16.23	14.3	13.76
EBIT	183.6	32.16	179.8	49.64	19.23
EBIT Margin	22.75%	5.67%	26.05%	13.00%	6.79%
Effective Tax Rate	12.46%	6.46%	12.61%	10.19%	17.72%
Revenue as Reported	-	567.27	690.11	382.01	283.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.